Latest News

Vesper Medical announces first enrolment in the VIVID trial

Vesper Medical recently announced initiation of its US Food and Drug Administration (FDA) investigational device exemption (IDE) study—VIVID (Venous stent for the iliofemoral vein investigational...

Features

Paul Gagne

The future of IVUS based therapies for venous leg ulcers

Writing for Venous News, Paul Gagne considers the future of intravascular ultrasound (IVUS) based therapies for venous leg ulcers (VLUs). He concludes that while...

A Deeper Dive into the Venovo™ Venous Stent System

Venous News talks with Gerard O'Sullivan, FSIR, FEBIR, University College Hospital, Galway, Ireland. This article is supported by BD Interventional. Disclosures: Dr. Gerard O'Sullivan reports...

Videos

Anthony Comerota (Alexandria, USA), global principal investigator of the VIVO trial, discusses the highlights of the 12-month results of the VIVO clinical study that were presented at VIVA 2020. While the safety and efficacy of the Zilver Vena stent, which...
Raghu Kolluri vascular medicine profile

Raghu Kolluri

John-Kaufman-profile

John Kaufman

Kurosh Parsi profile

Kurosh Parsi